Demo Sign up Log In

Biocryst Pharmaceuticals Inc (BCRX)

Operating Expenses

$534.75M

TTM · Period ending: Jun 30, 2026 · USD

BCRX Operating Expenses

Latest reported$534.75Mperiod endingJun 30, 2026

Latest reported$534.75Mperiod endingJun 30, 2026

BCRX TTM Operating Expenses ($2.60M → $534.75M)

TTM operating expenses

High-resolution chart · PNG

BCRX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	13,129,608
Mar 31, 2001	13,298,608
Dec 31, 2000	13,548,387
Sep 30, 2000	12,697,779
Jun 30, 2000	12,466,779
Mar 31, 2000	11,618,779
Dec 31, 1999	11,200,000
Sep 30, 1999	11,000,000
Jun 30, 1999	12,000,000
Mar 31, 1999	12,700,000
Dec 31, 1998	13,000,000
Sep 30, 1998	14,200,000
Jun 30, 1998	13,600,000
Mar 31, 1998	13,700,000
Dec 31, 1997	14,000,000
Sep 30, 1997	5,600,000
Jun 30, 1997	5,300,000
Mar 31, 1997	4,800,000
Dec 31, 1996	3,200,000
Sep 30, 1996	3,600,000
Jun 30, 1996	3,100,000
Mar 31, 1996	1,800,000
Dec 31, 1995	3,000,000
Sep 30, 1995	8,000,000
Jun 30, 1995	6,300,000
Mar 31, 1995	5,200,000
Dec 31, 1994	2,600,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.